# 2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism

> **NCT02214862** · EARLY_PHASE1 · COMPLETED · sponsor: **Fundacion Clinic per a la Recerca Biomédica** · enrollment: 40 (actual)

## Conditions studied

- Progressive Supranuclear Palsy
- Multi-System Atrophy
- Parkinsonism

## Interventions

- **DRUG:** [F18]-FDDNP

## Key facts

- **NCT ID:** NCT02214862
- **Lead sponsor:** Fundacion Clinic per a la Recerca Biomédica
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2015-12
- **Final completion:** 2016-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02214862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02214862, "2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02214862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*